MAIA Share Price Performance
US$1.34
-0.57 (-29.84%)
Price US$1.34
Share Pricen/a
MAIA Biotechnology, Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 9 Fair Values set on narratives written by author
MAIA Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
MAIA Biotechnology, Inc. Key Details
About MAIA
- Founded
- 2018
- Employees
- 13
- CEO
- WebsiteView website
MAIA Biotechnology, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the development of targeted immunotherapies for cancer. Its lead product Ateganosine, a telomere-targeting agent currently in clinical development to evaluate its activity in Non-Small Cell Lung Cancer (NSCLC). The company was incorporated in 2018 and is headquartered in Chicago, Illinois.
